A BRCA1-Like, 25-Gene Assay Predicts for Anthracycline-Chemosensitivity in Sporadic Triple-Negative Breast Cancer.

被引：0
|
作者：
Rodriguez, A. A. [1 ]
Rimawi, M. [1 ]
Wu, M-F [1 ]
Dave, B. [1 ]
Wong, H. [1 ]
Landis, M. [1 ]
Cairo, M. [1 ]
Pavlick, A. [1 ]
Froehlich, A. [1 ]
Chamness, G. [1 ]
Hilsenbeck, S. G. [1 ]
Lewis, M. T. [1 ]
Osborne, C. K. [1 ]
Chang, J. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：509S / 509S
页数：1
相关论文
共 50 条
  • [1] BRCA1 gene expression signature predicts for anthracycline-chemosensitivity in triple-negative breast cancer.
    Rodriguez, A. A.
    Makris, A.
    Harrison, M. K.
    Ostler, P. J.
    Froehlich, A.
    Pavlick, A.
    Wong, H.
    Tsimelzon, A.
    Sexton, K.
    Hilsenbeck, S. G.
    Lewis, M. T.
    Rimawi, M.
    Osborne, C. K.
    Chang, J. C.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 358S - 358S
  • [2] BRCA1-Like Triple Negative Tumors: Clinicopathological Variables and Chemosensitivity to Alkylating Agents
    Wesseling, J.
    Lips, E. H.
    Oonk, A. M. M.
    Smits, R. M.
    van Rijn, C. C. M.
    Mulder, L.
    Laddach, N.
    Savola, S. S.
    Wessels, L. F. A.
    Nederiof, P. M.
    Rodenhuis, S.
    Imholz, A. L. T.
    [J]. CANCER RESEARCH, 2011, 71
  • [3] Characterisation of distinct subgroups of BRCA1-like triple-negative breast cancers with multiomics data analysis
    Chan, T. W. S.
    Opdam, M.
    Schouten, P.
    De Boo, L.
    Hilbers, F. S.
    Linn, S. C.
    De Menezes, R. X.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S592 - S593
  • [4] A study of triple-negative breast cancer patients tested with a 25-gene panel of hereditary cancer genes.
    Sandbach, John F.
    Patel, Gayle
    King, Elisabeth
    Evans, Brent
    Kidd, John
    Langer, Lucy R.
    Brown, Krystal
    Wenstrup, Richard J.
    Saam, Jennifer
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] BRCA1-like signature in triple negative breast cancers within the RATHER (Rational Therapy for Breast Cancer) Consortium
    Severson, Tesa
    Peeters, Justine
    Majewski, Ian
    Bosma, Astrid
    Chin, Suet-Feung
    Caldas, Carlos
    Simon, Iris
    Bernards, Rene
    Linn, Sabine
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [6] BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer
    Jacot, William
    Lopez-Crapez, Evelyne
    Mollevi, Caroline
    Boissiere-Michot, Florence
    Simony-Lafontaine, Joelle
    Ho-Pun-Cheung, Alexandre
    Chartron, Elodie
    Theillet, Charles
    Lemoine, Antoinette
    Saffroy, Raphael
    Lamy, Pierre-Jean
    Guiu, Severine
    [J]. CANCERS, 2020, 12 (04)
  • [7] BRCA1 methylation in triple-negative breast cancer
    Kawachi, A.
    Okochi-Takada, E.
    Shimoi, T.
    Shimomura, A.
    Kodaira, M.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Ushijima, T.
    Tamura, K.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 28 - 29
  • [8] BRCA1 testing for triple-negative breast cancer
    Bennet, Neil
    [J]. LANCET ONCOLOGY, 2012, 13 (04): : E143 - E143
  • [9] Clinically relevant gene signatures in triple-negative and basal-like breast cancer.
    Rody, A.
    Karn, T.
    Liedtke, C.
    Ruckhaeberle, E.
    Hanker, L.
    Pusztai, L.
    Mueller, V.
    Schmidt, M.
    Holtrich, U.
    Kaufmann, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer
    X. Zhu
    L. Shan
    F. Wang
    J. Wang
    F. Wang
    G. Shen
    X. Liu
    B. Wang
    Y. Yuan
    J. Ying
    H. Yang
    [J]. Breast Cancer Research and Treatment, 2015, 150 : 479 - 486
12345